{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:18:29Z","timestamp":1783437509326,"version":"3.54.6"},"reference-count":3,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2026,7,7]]},"DOI":"10.1001\/jama.2026.5239","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:30:39Z","timestamp":1779982239000},"page":"74","source":"Crossref","is-referenced-by-count":0,"title":["Nalbuphine for Cough Caused by Idiopathic Pulmonary Fibrosis"],"prefix":"10.1001","volume":"336","author":[{"given":"Alyn Hugh","family":"Morice","sequence":"first","affiliation":[{"name":"Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Sykes","sequence":"additional","affiliation":[{"name":"Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Hart","sequence":"additional","affiliation":[{"name":"Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham, England"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"jle260063r1","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jama.2025.26179","article-title":"Oral nalbuphine in idiopathic pulmonary fibrosis\u2013associated cough: the CORAL randomized clinical trial.","volume":"335","author":"Molyneaux","year":"2026","journal-title":"JAMA"},{"issue":"9","key":"jle260063r2","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1021\/jm061327z","article-title":"Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at \u00b5, d, and ? opioid receptors.","volume":"50","author":"Peng","year":"2007","journal-title":"J Med Chem"},{"key":"jle260063r3","article-title":"Late breaking abstract\u2014efficacy and safety of nalbuphine extended-release in refractory chronic cough: results from the phase 2a RIVER trial.","volume":"66","author":"Smith","year":"2025","journal-title":"Eur Respir J"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2849514\/jama_morice_2026_le_260063_1782490551.6597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:12:49Z","timestamp":1783437169000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2849514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":3,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7,7]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2026.5239","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}